Clinical Trial Detail

NCT ID NCT02808442
Title Study of UCART19 in Pediatric Patients With Relapsed/Refractory B Acute Lymphoblastic Leukemia (PALL)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Institut de Recherches Internationales Servier
Indications

childhood B-cell acute lymphoblastic leukemia

Therapies

UCART19

Age Groups: child

No variant requirements are available.